Study List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Report Bug
Study List
You are on Page 758 of 776:
748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768

Clinical Studies

NCT Number Gene Therapy Sponsor Status Brief Title Phase View
NCT00116766 London School of Hygiene and Tropical Medicine COMPLETED Field Evaluation of Plant-based Mosquito Control PHASE2 View
NCT00116558 Edward Kasaraskis COMPLETED Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation NA View
NCT00116532 Massachusetts General Hospital COMPLETED Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD) PHASE4 View
NCT00116493 Johns Hopkins Bloomberg School of Public Health COMPLETED Severe Anemia Treatment Trials, Pakistan PHASE3 View
NCT00116467 Cell Genesys COMPLETED Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia PHASE2 View
NCT00116428 Positive Gene Therapy Biosense Webster, Inc. COMPLETED NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation PHASE3 View
NCT00116402 University of Chicago COMPLETED A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations PHASE1 View
NCT00116350 Gynuity Health Projects COMPLETED Misoprostol for the Treatment of Postpartum Hemorrhage NA View
NCT00116259 Federal University of Rio Grande do Sul COMPLETED Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) NA View
NCT00116233 SyntheMed UNKNOWN Pediatric Multicenter Study of REPEL-CV PHASE2 View
NCT00116220 Dana-Farber Cancer Institute COMPLETED Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer PHASE3 View
NCT00116194 National Institute on Aging (NIA) COMPLETED The LIFE Study: Lifestyle Interventions and Independence for Elders, Pilot PHASE1 View
NCT00116168 MedImmune LLC COMPLETED Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528 PHASE1 View
NCT00116103 Astellas Pharma Inc COMPLETED A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma PHASE2 View
NCT00116051 University of Aarhus COMPLETED A Comparison of Two Surface Materials (Tantalum Versus Titanium Fiber Mesh) of Acetabular Components in Hip Arthroplasty NA View
NCT00116012 ARCA Biopharma, Inc. COMPLETED Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32 PHASE2 View
NCT00115960 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults PHASE1 View
NCT00115934 Positive Gene Therapy Carelon Research COMPLETED Comparison of Two Types of Shunts in Infants With Single Ventricle Defect Undergoing Staged Reconstruction--Pediatric Heart Network NA View
NCT00115895 University of Helsinki UNKNOWN The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy PHASE3 View
NCT00115869 Fred Hutchinson Cancer Center COMPLETED Hutchinson Smoking Prevention Project PHASE3 View
NCT00115856 Brigham and Women's Hospital COMPLETED Imaging of Plaque With Magnetic Resonance Imaging (MRI) NA View
NCT00115804 Positive Gene Therapy University of Cincinnati COMPLETED Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia PHASE3 View
NCT00115661 Positive Gene Therapy Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) TERMINATED Use of Rosiglitazone in the Treatment of Endometriosis PHASE2 View
NCT00115635 Herlev Hospital COMPLETED Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer PHASE1 View
NCT00115557 Agency for Healthcare Research and Quality (AHRQ) COMPLETED Delivery of Preventive Services in Primary Care NA View
NCT00115518 Heidelberg University COMPLETED Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) PHASE2 View
NCT00115505 Alliance for Clinical Trials in Oncology COMPLETED Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer View
NCT00115492 GlaxoSmithKline COMPLETED Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations PHASE4 View
NCT00115466 Cellerix UNKNOWN Autologous Stem Cells Derived From Lipoaspirates for the Non-Surgical Treatment of Complex Perianal Fistula PHASE2 View
NCT00115258 Boston Children's Hospital COMPLETED Nutrition Support in Pediatric Stem Cell Transplantation PHASE3 View
NCT00115232 Boston Children's Hospital COMPLETED Inflammatory Profiles of Children at High Risk for Atherosclerosis View
NCT00115193 Amgen COMPLETED Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma PHASE2 View
NCT00115167 Amgen COMPLETED A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study PHASE3 View
NCT00115102 University of Aarhus COMPLETED Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls PHASE4 View
NCT00115050 Tibotec Pharmaceuticals, Ireland COMPLETED TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options PHASE3 View
NCT00114959 ChemGenex Pharmaceuticals TERMINATED Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) PHASE2 View
NCT00114933 Arribas, Jose R., M.D. COMPLETED "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects PHASE4 View
NCT00114920 Graceway Pharmaceuticals, LLC COMPLETED Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults PHASE2 View
NCT00114894 University of Minnesota COMPLETED Prevention of Jellyfish Stings PHASE3 View
NCT00114868 Johns Hopkins Bloomberg School of Public Health COMPLETED Vitamin A Supplementation in Newborns Study PHASE3 View
NCT00114803 Boston Children's Hospital COMPLETED Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease NA View
NCT00114660 American University of Beirut Medical Center COMPLETED Cocoa Butter for Prevention of Stretch Marks NA View
NCT00114634 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) COMPLETED Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome PHASE2 View
NCT00114595 University of Stellenbosch COMPLETED Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia PHASE4 View
NCT00114569 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) COMPLETED Lorazepam for the Treatment of Status Epilepticus in Children PHASE1 View
NCT00114556 Royal Prince Alfred Hospital, Sydney, Australia COMPLETED The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients PHASE4 View
NCT00114504 Kurume University COMPLETED Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation NA View
NCT00114361 Foundation for Liver Research COMPLETED 48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection PHASE3 View
NCT00114335 Luzerner Kantonsspital COMPLETED Epidemiologic Data of Patients in a Teaching Hospital View
NCT00114257 National Cancer Institute (NCI) COMPLETED Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders PHASE1 View
NCT00114218 Gynecologic Oncology Group COMPLETED Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer PHASE2 View
NCT00114205 University of Virginia COMPLETED Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion PHASE1 View
NCT00114192 University of Virginia COMPLETED Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer PHASE2 View
NCT00114166 Gynecologic Oncology Group COMPLETED Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer PHASE2 View
NCT00113958 Amgen COMPLETED Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels PHASE2 View
NCT00113932 University of Arkansas COMPLETED UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma PHASE2 View
NCT00113893 Scios, Inc. COMPLETED SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. PHASE2 View
NCT00113867 National Institute on Aging (NIA) COMPLETED Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal Women View
NCT00113802 Gilead Sciences TERMINATED Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia PHASE2 View
NCT00113750 Allergy Therapeutics COMPLETED Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen PHASE2 View
NCT00113659 Montefiore Medical Center COMPLETED Use of a Probiotic Supplement to Prevent Asthma in Infants NA View
NCT00113633 Positive Gene Therapy Children's Hospital of Philadelphia COMPLETED Educational Video for Improving Follow-up After an Emergency Department Visit for Asthma NA View
NCT00113620 Avanir Pharmaceuticals COMPLETED Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy PHASE3 View
NCT00113594 Eli Lilly and Company COMPLETED Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder PHASE3 View
NCT00113568 Positive Gene Therapy Ferring Pharmaceuticals COMPLETED Safety Study of XP12B in Women With Menorrhagia PHASE3 View
NCT00113503 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) TERMINATED Imuran Dosing in Crohn's Disease Study PHASE2 View
NCT00113451 University Hospital of North Norway COMPLETED Radial Artery Bypass Graft Study of Tromsø View
NCT00113360 M.D. Anderson Cancer Center COMPLETED RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma PHASE2 View
NCT00113334 M.D. Anderson Cancer Center COMPLETED Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer PHASE1 View
NCT00113308 GlaxoSmithKline COMPLETED COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis PHASE3 View
NCT00113295 Massachusetts General Hospital COMPLETED Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder PHASE4 View
NCT00113269 Astellas Pharma Inc COMPLETED Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients PHASE4 View
NCT00113256 Astex Pharmaceuticals, Inc. TERMINATED Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer PHASE2 View
NCT00113204 Infinity Pharmaceuticals, Inc. COMPLETED Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma PHASE1 View
NCT00113061 Positive Gene Therapy National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults NA View
NCT00113035 Genzyme, a Sanofi Company COMPLETED Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease View
NCT00112957 Ludwig Institute for Cancer Research COMPLETED Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer PHASE2 View
NCT00112918 Hoffmann-La Roche COMPLETED Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer PHASE3 View
NCT00112905 National Cancer Institute (NCI) TERMINATED Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium PHASE2 View
NCT00112892 Roswell Park Cancer Institute COMPLETED Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00112866 Positive Gene Therapy National Cancer Institute (NCI) TERMINATED Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme PHASE2 View
NCT00112827 City of Hope Medical Center COMPLETED Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma PHASE1 View
NCT00112658 Positive Gene Therapy UNICANCER COMPLETED Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer PHASE2 View
NCT00112632 Technical University of Munich COMPLETED Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor PHASE2 View
NCT00112593 Fred Hutchinson Cancer Center COMPLETED Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer NA View
NCT00112567 Fred Hutchinson Cancer Center COMPLETED Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer PHASE1 View
NCT00112502 M.D. Anderson Cancer Center COMPLETED Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme PHASE2 View
NCT00112359 Gilead Sciences COMPLETED International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa PHASE3 View
NCT00112333 Positive Gene Therapy Massachusetts General Hospital COMPLETED Defining Central Circuits of Pain NA View
NCT00112320 Boston Children's Hospital COMPLETED Comparison of Two Pulmonary Valve Replacement Methods to Treat Tetralogy of Fallot NA View
NCT00112294 Eli Lilly and Company COMPLETED Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer PHASE3 View
NCT00112268 Virginia Ambulatory Care Outcomes Research Network COMPLETED Quitlink : A Leveraging Solution to Tobacco Counseling PHASE3 View
NCT00112203 Forest Laboratories COMPLETED Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia PHASE3 View
NCT00112151 Positive Gene Therapy University of Colorado, Denver COMPLETED TEAM: Testosterone Supplementation and Exercise in Elderly Men PHASE2 View
NCT00112112 MedImmune LLC COMPLETED Safety Study to Evaluate FluMist in Immunocompromised Children PHASE1 View
NCT00112060 Spectrum Pharmaceuticals, Inc WITHDRAWN A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) PHASE1 View
NCT00112034 Biogen COMPLETED AVONEX® Combination Trial - "ACT" PHASE4 View
NCT00111995 Amgen COMPLETED Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis PHASE4 View
NCT00111969 Vasogen COMPLETED ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy PHASE3 View
NCT00111956 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) COMPLETED Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome PHASE2 View
NCT00111904 Theradex COMPLETED Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer PHASE2 View
NCT00111761 Positive Gene Therapy Amgen COMPLETED Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer PHASE2 View
NCT00111735 Positive Gene Therapy Sir Charles Gairdner Hospital UNKNOWN Thyroxine Titration Study PHASE4 View
NCT00111657 Positive Gene Therapy John Sundy COMPLETED Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout PHASE2 View
NCT00111618 Antisoma Research COMPLETED Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer PHASE2 View
NCT00111605 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults PHASE1 View
NCT00111592 Maastricht University Medical Center COMPLETED Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice NA View
NCT00111566 Cardiology Research UBC COMPLETED BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention PHASE4 View
NCT00111358 Massachusetts General Hospital COMPLETED Study of Lifestyle Modification in HIV Lipodystrophy NA View
NCT00111332 Massachusetts General Hospital COMPLETED Study of Home-Based Resistance and Strength Training in HIV-Infected Women NA View
NCT00111293 National Institute of Mental Health (NIMH) COMPLETED Attention and Visual Perception View
NCT00111267 Wageningen University COMPLETED Oral Vitamin B12 Supplementation and Cognitive Performance in Elderly People NA View
NCT00111202 Sarah Lawrence College UNKNOWN Schizophrenia and Genetic Counseling View
NCT00111150 Centers for Disease Control and Prevention TERMINATED Botswana Tenofovir Oral HIV Prophylaxis Trial PHASE2 View
NCT00111059 University Hospital, Saarland UNKNOWN Primary Prevention Study: Study on Obesity, Cardiovascular and Psycho-Social Characteristics in the City of Merzig View
NCT00111020 Bayer COMPLETED Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma PHASE3 View
NCT00110994 Bayer COMPLETED Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma PHASE2 View
NCT00110968 Forest Laboratories COMPLETED Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia PHASE3 View
NCT00110903 Amgen COMPLETED Treatment for Subjects With Active Rheumatoid Arthritis (RA) PHASE3 View
NCT00110851 Wellstat Therapeutics COMPLETED Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) PHASE2 View
NCT00110760 ZARS Pharma Inc. COMPLETED S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face PHASE3 View
NCT00110734 ZARS Pharma Inc. COMPLETED S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults PHASE3 View
NCT00110695 NSABP Foundation Inc COMPLETED Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer PHASE2 View
NCT00110669 Cooperative International Neuromuscular Research Group COMPLETED High-dose Prednisone in Duchenne Muscular Dystrophy PHASE3 View
NCT00110656 Amgen COMPLETED Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation View
NCT00110604 Wageningen University COMPLETED The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and Hearing NA View
NCT00110461 Positive Gene Therapy Otsuka Pharmaceutical Development & Commercialization, Inc. COMPLETED Aripiprazole in Children and Adolescents With Bipolar I Disorder PHASE3 View
NCT00110435 Organon and Co COMPLETED A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077) PHASE3 View
NCT00110357 Eli Lilly and Company COMPLETED Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors PHASE1 View
NCT00110318 The University of Queensland COMPLETED Trial of Physiotherapy and Corticosteroid Injections in Lateral Epicondylalgia PHASE3 View
NCT00110305 Tibotec Pharmaceuticals, Ireland COMPLETED A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines PHASE2 View
NCT00110292 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) UNKNOWN Preventing Learning Problems in Young Children: A Public Health and Physician-Based Outreach PHASE1 View
NCT00110266 Novartis Pharmaceuticals COMPLETED Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients PHASE2 View
NCT00110227 Beth Israel Deaconess Medical Center COMPLETED Tai Chi Mind-Body Therapy for Chronic Heart Failure PHASE3 View
NCT00110058 Fred Hutchinson Cancer Center COMPLETED Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia PHASE2 View
NCT00110032 National Cancer Institute (NCI) TERMINATED Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors PHASE1 View
NCT00110006 Positive Gene Therapy Case Comprehensive Cancer Center WITHDRAWN Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma NA View
NCT00109993 Case Comprehensive Cancer Center COMPLETED Campath-1H + FK506 and Methylprednisolone for GVHD PHASE2 View
NCT00109967 National Cancer Institute (NCI) COMPLETED CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE2 View
NCT00109928 SWOG Cancer Research Network COMPLETED S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma PHASE2 View
NCT00109850 SWOG Cancer Research Network TERMINATED S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer PHASE2 View
NCT00109759 Allergy Therapeutics WITHDRAWN Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A) PHASE1 View
NCT00109733 EMD Serono COMPLETED Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency PHASE3 View
NCT00109720 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) COMPLETED Evaluation of Diabetes Self-Management Consultant Care NA View
NCT00109668 Teva Branded Pharmaceutical Products R&D, Inc. COMPLETED Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids PHASE3 View
NCT00109603 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy NA View
NCT00109551 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) COMPLETED Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal PHASE3 View
NCT00109512 Abbott COMPLETED Endometriosis Trial: Study of NBI-56418 in Endometriosis PHASE2 View
NCT00109460 Inflexxion, Inc. COMPLETED Tobacco Cessation Field Study for Adults in Recovery - 1 PHASE2 View
NCT00109434 Jaeb Center for Health Research COMPLETED Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes View
NCT00109395 The Emmes Company, LLC COMPLETED Lorazepam Sedation for Critically Ill Children PHASE2 View
NCT00109369 Positive Gene Therapy National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) COMPLETED Vermont Diabetes Information System NA View
NCT00109356 Novacea UNKNOWN Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia PHASE1 View
NCT00109304 DynPort Vaccine Company LLC, A GDIT Company WITHDRAWN Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine PHASE1 View
NCT00109161 PDL BioPharma, Inc. COMPLETED Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis PHASE2 View
NCT00109135 Merck Sharp & Dohme LLC COMPLETED A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007) PHASE2 View
NCT00109057 Genentech, Inc. COMPLETED An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study PHASE2 View
NCT00109018 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Biomarkers for Cardiovascular Disease View
NCT00109005 National Cancer Institute (NCI) COMPLETED Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma PHASE2 View
NCT00108992 Positive Gene Therapy Nuvo Research Inc. COMPLETED Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee Osteoarthritis PHASE3 View
NCT00108758 Novo Nordisk A/S COMPLETED Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia PHASE2 View
NCT00108732 National Cancer Institute (NCI) COMPLETED A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer PHASE2 View
NCT00108667 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Talampanel to Treat Parkinson's Disease PHASE2 View
NCT00108602 US Department of Veterans Affairs WITHDRAWN Sleep Apnea: Mechanism and Cerebrovascular Consequences NA View
NCT00108550 US Department of Veterans Affairs COMPLETED Chronic Low Back Pain Research Project PHASE2 View
NCT00108459 US Department of Veterans Affairs COMPLETED Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes PHASE3 View
NCT00108433 Pfizer TERMINATED Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections PHASE3 View
NCT00108420 US Department of Veterans Affairs COMPLETED Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance PHASE4 View
NCT00108394 US Department of Veterans Affairs COMPLETED Osteopenia and Renal Osteodystrophy: Evaluation and Management PHASE4 View
NCT00108368 US Department of Veterans Affairs COMPLETED The Effects of Risperidone and Olanzapine on Thinking PHASE4 View
NCT00108303 VA Office of Research and Development COMPLETED Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes View
NCT00108251 US Department of Veterans Affairs COMPLETED Aldosterone Antagonism in Diastolic Heart Failure PHASE4 View
NCT00108160 US Department of Veterans Affairs COMPLETED Preventing Staphylococcal (Staph) Infection PHASE4 View
NCT00108134 Positive Gene Therapy Peplin COMPLETED Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma PHASE2 View
NCT00108095 GlaxoSmithKline COMPLETED A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting PHASE2 View
NCT00108069 National Cancer Institute (NCI) COMPLETED Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors PHASE2 View
NCT00108056 National Cancer Institute (NCI) TERMINATED Enzastaurin to Treat Recurrent Brain Tumor PHASE1 View
NCT00108004 AstraZeneca COMPLETED Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus PHASE3 View
NCT00107900 Daiichi Sankyo COMPLETED Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement PHASE2 View
NCT00107861 Biogen COMPLETED Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases PHASE1 View
NCT00107835 ZARS Pharma Inc. COMPLETED Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults PHASE3 View
NCT00107757 GlaxoSmithKline COMPLETED Seasonal Allergic Rhinitis In Pediatric Subjects PHASE3 View
NCT00107718 GlaxoSmithKline COMPLETED Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma PHASE2 View
NCT00107705 Allergy Therapeutics COMPLETED Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing PHASE1 View
NCT00107692 University of Wollongong UNKNOWN Can a Physical Activity Skill Development and Parent-Centered Dietary Intervention Help Combat Child Obesity? NA View
NCT00107666 Critical Therapeutics TERMINATED CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB) PHASE2 View
NCT00107458 Children's Oncology Group COMPLETED Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors PHASE1 View
NCT00107432 National Cancer Institute (NCI) COMPLETED Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. PHASE2 View
NCT00107393 Tohoku University COMPLETED Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer PHASE2 View
NCT00107367 The Cleveland Clinic UNKNOWN Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor PHASE1 View
NCT00107250 NCIC Clinical Trials Group COMPLETED AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07) PHASE1 View
NCT00107159 Jonsson Comprehensive Cancer Center COMPLETED Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma PHASE2 View
NCT00107120 Forest Laboratories COMPLETED The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder PHASE3 View
NCT00107094 Celgene Corporation COMPLETED Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer PHASE1 View
NCT00107068 Positive Gene Therapy University of Sydney COMPLETED Exercise Training and Walking Ability After Chronic Stroke NA View
NCT00107003 National Cancer Institute (NCI) COMPLETED GW572016 to Treat Recurrent Malignant Brain Tumors PHASE2 View
NCT00106951 University of North Carolina, Chapel Hill COMPLETED Effects of Neighborhood SES on Coronary Heart Disease Burden in Communities - Ancillary to ARIC View
NCT00106860 Jazz Pharmaceuticals COMPLETED A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder PHASE3 View
NCT00106834 Positive Gene Therapy Centocor, Inc. COMPLETED A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis PHASE3 View
NCT00106795 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS View